Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
More severe manifestations and poorer short-term prognosis of ganglioside-associated guillain-barré syndrome in northeast china.
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.
The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
Evaluating sex hormone levels in reproductive age women with multiple sclerosis and their relationship with disease severity.
Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.
Assessing risks of multiple sclerosis therapies.
Sex-specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline.
Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology.
Established and novel disease-modifying treatments in multiple sclerosis.
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures.
Stability of rating scale response category interpretations in neurological disorders.
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
Muscle oxygen consumption by NIRS and mobility in multiple sclerosis patients.
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Do not judge a cell by its cover-diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation.
Laser speckle imaging to improve clinical outcomes for patients with trigeminal neuralgia undergoing radiofrequency thermocoagulation.
Bone marrow-derived macrophages and the CNS: An update on the use of experimental chimeric mouse models and bone marrow transplantation in neurological disorders.
Human neural progenitor cells in central nervous system lesions.
Cryoglobulinaemia (IgG-κ-type and IgM-γ-type) with Occluding Leukocytoclastic Vasculitis in a Patient with Vitiligo and Demyelinating Polyneuropathy.
Biochemical Pharmacology of the Sigma-1 Receptor.
Acrolein-mediated conduction loss is partially restored by potassium channel blockers.
Pages
« first
‹ previous
…
547
548
549
550
551
552
553
554
555
…
next ›
last »